Table 4.
Comparisons of angiogenic factors concentrations (pg/ml) among the patients undergoing modified radical mastectomy between the two groups
| Group SEV (n = 23) |
GroupTIVA (n = 24) | P -value | |
|---|---|---|---|
| Preoperative values | |||
| VEGF-C | 104 (88–173) | 140 (88–203) | 0.285 |
| TGF-β | 183(114–272) | 218(108–305) | 0.666 |
| Postoperative values | |||
| VEGF-C | 197 (149–236) | 149(110–280) | 0.193 |
| TGF-β | 184(135–299) | 176(121–362) | 0.708 |
| Pre-post changesa | |||
| VEGF-C | 86(30–116) | 22(−19–52) | 0.001 |
| TGF-β | 12(−49–43) | 10(− 42–51) | 0.874 |
Values are median (25–75% interquartile range)
Abbreviation: SEV sevoflurane, TIVA total intravenous anesthesia, VAS visual analogue scale, VEGF vascular endothelial growth factor, TGF transforming growth factor
aPre-post changes: postoperative values minus preoperative values